NASDAQ:CLOV Clover Health Investments Q3 2026 Earnings Date & Estimates $4.58 +0.02 (+0.44%) Closing price 10/8/2026 04:00 PM EasternExtended Trading$5.01 +0.44 (+9.50%) As of 10/8/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Clover Health Investments is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Clover Health Investments in Q3 2026Clover Health Investments is expected to post earnings of -$0.00 per share on revenue of $740.31 million. In the same quarter a year earlier Clover Health Investments reported -$0.05 per share on revenue of $496.65 million. Clover Health Investments last reported on August 5, 2026, posting $0.05 per share and beating the $0.04 consensus estimate. Clover Health Investments has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.00Expected Revenue$740.31 millionPrior-Year EPS-$0.05Prior-Year Revenue$496.65 millionExpected Revenue Growth+49.1%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.05 (Beat by +$0.01)Last Quarter Revenue$743.17 millionEPS Beat Rate5 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Clover Health Investments Q3 2026 Earnings FAQ When does Clover Health Investments report Q3 2026 earnings? Clover Health Investments (NASDAQ:CLOV) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. What time is Clover Health Investments' Q3 2026 earnings call? Clover Health Investments' Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Clover Health Investments? Analysts expect Clover Health Investments to post earnings of -$0.00 per share for Q3 2026. How much revenue is Clover Health Investments expected to report? The consensus revenue estimate for Clover Health Investments is $740.31 million for Q3 2026. Clover Health Investments Earnings HeadlinesClover Health Investments Climbs After PPO Medicare Advantage Plans Rated Five Stars48 minutes ago | marketwatch.comClover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027October 8 at 6:45 PM | globenewswire.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country. | Banyan Hill Publishing (Ad)At 67, He’ll Keep His Clover Medicare Advantage Plan for 2027. The Premium Will Stay $0. The Most He Can Be Billed Will Jump $1,144October 8 at 7:00 AM | 247wallst.comClover Health to Report Third Quarter 2026 Financial Results on November 4, 2026October 7 at 4:05 PM | globenewswire.comClover Health Investments (CLOV) Unveils 2027 Medicare Plans, Is The Stock Still Cheap?October 4, 2026 | finance.yahoo.comSee More Clover Health Investments Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Clover Health Investments? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clover Health Investments and other key companies, straight to your email. Email Address About Clover Health InvestmentsClover Health Investments (NASDAQ:CLOV) is a healthcare technology and Medicare Advantage company headquartered in Franklin, Tennessee. Through its insurance subsidiary, Clover Health Insurance Company, the company offers Medicare Advantage plans to eligible beneficiaries in select counties across the United States. Its plans are designed to provide coverage for hospital, medical and supplemental healthcare services through a managed-care structure. Clover’s technology platform, Clover Assistant, is intended to support physicians by organizing patient information, identifying potential care needs and helping providers coordinate treatment. The platform is designed to give clinicians data-driven insights during patient visits while helping Clover manage care for its Medicare Advantage members. Clover Health was founded in 2012 and became a publicly traded company in 2021 through a business combination with Social Capital Hedosophia Holdings Corp. III. The company has focused primarily on the Medicare Advantage market and has also participated in value-based care initiatives. Andrew Toy serves as chief executive officer, having previously held technology leadership roles at Clover.View Clover Health Investments ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Levi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueSkydance Just Became a Media Giant—With an $80 Billion Debt LoadConstellation Brands Beat Earnings, But Beer Demand Is Still a ProblemTesla's EV Delivery Beat Is In, So What Happens Now?BigBear.ai Is Heavily Shorted—and Its Fundamentals Are Starting to ChangePenguin Solutions Is Soaring as AI Memory Demand Explodes Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
